Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: A retrospective study

Journal of Medical Imaging and Radiation Oncology

Volumn 54, Issue 5, 2010, Pages 421-430

  Ooi, Chin Chin ^a   Low, Su Chong Albert ^a   Schneider Kolsky, Michal ^b   Lombardo, Paul ^b   Lim, Sze Ying ^a   Abu Bakar, Rafidah ^a   Lo, Richard Hoau Gong ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b MONASH UNIVERSITY   (Australia)

Author keywords

carcinoma; contrast media; hepatocellular; liver neoplasm; microbubble; ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOSPHOLIPIDS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78349294196     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2010.02195.x     Document Type: Article

References (25)

1. Rettenbacher T,. Focal liver lesions: role of contrast-enhanced ultrasound. Eur J Radiol 2007; 64: 173 - 82.
2. Rettenbacher T,. Our experiences using contrast enhanced ultrasound in focal liver lesions. Eur J Radiol Suppl 2005; 15 (Suppl 5): E93 - 7.
3. Perazella MA, Rodby RA,. Gadolinium use in patients with kidney disease: a cause for concern. Semin Dial 2007; 20: 179 - 85.
4. Catalano O, Migaleddu V, Quaia E, Caruso G,. Terminology for contrast-enhanced sonography. J Ultrasound Med 2007; 26: 717 - 30.
5. Quaia E, Calliada F, Bertolotto M, etal. Characterization of focal liver lesions with contrast-specific US modes and a sulphur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232: 420 - 30.
6. Bolondi L, Correas JM, Lencioni R, Weskott HP, Piscaglia F,. New perspective for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 2007; 39: 187 - 95.
7. Claudon M, Cosgrove D, Albrecht T, etal. Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) - Update 2008. Ultraschall Med 2008; 29: 28 - 44.
8. Jung EM, Clevert DA, Schreyer AG, etal. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two center study. World J Gastroenterol 2007; 13: 6356 - 64.
9. Li R, Guo YL, Hua X, etal. Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast enhanced sonography with contrast enhanced CT. J Clin Ultrasound 2007; 35: 109 - 17.
10. Nicolau C, Vilana R, Bru C,. The use of contrast enhanced ultrasound in the management of the cirrhotic patient and for detection of HCC. Eur J Radiol Suppl 2004; 14 (Suppl 8): P63 - 71.
11. Greis C,. Technology overview: SonoVue (Bracco, Milan). Eur J Radiol Suppl 2004; 14 (Suppl 8): P11 - 5.
12. Ricci P, Laghi A, Cantisani V, etal. Contrast-enhanced sonography with SonoVue: enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI. Am J Roentgenol 2005; 184: 821 - 7.
13. Dietrich CF, Kratzer W, Strobe D, etal. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699 - 705.
14. Solbiati L, Tonolini M, Cova L,. Monitoring RF ablation. Eur J Radiol Suppl 2004; 14 (Suppl 8): P34 - 42.
15. Albrecht T, Hohmann J, Oldenburg A, Shrok J, Wolf K-J,. Detection and characterization of liver metastases. Eur J Radiol Suppl 2004; 14 (Suppl 8): P25 - 33.
16. D'Onofrio M, Martone E, Faccioli N, Zamboni G, Malago R, Pozzi-Mucelli R,. Focal liver lesions: sinusoidal phase of CEUS. Abdom Imaging 2006; 31: 529 - 36.
17. Dai Y, Chen MH, Yin SS, etal. Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions? Invest Radiol 2007; 42: 596 - 603.
18. Nicolau C, Catala V, Vilana R,. Evaluation of hepato-cellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14: 1092 - 9.
19. Wen YL, Kudo M, Zheng RQ, etal. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. Am J Roentgenol 2004; 182: 1019 - 26.
20. Ungermann L, Elias P, Zizka J, Ryska P, Klzo L,. Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol 2007; 63: 290 - 4.
21. Wilson SR, Jang HJ, Kim TK, Iijima H, Kamiyama N, Burns PN,. Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. Am J Roentgenol 2008; 190: 691 - 5.
22. Vilana R, Bianchi L, Varela M, etal. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 2006; 16: 2454 - 62.
23. Meloni MF, Livraghi T, Filice C, etal. Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma. Liver Int 2005; 25: 954 - 61.
24. Catalano O, Nunziata A, Lobianco R, Siani A,. Real-time harmonic contrast material- specific US of focal liver lesions. Radiographics 2005; 25: 333 - 49.
25. Lencioni R,. European federation of societies for ultrasound in medicine and biology (EFSUMB) guidelines for the use of contrast agents in liver ultrasound: what is the impact in clinical practice? Eur Radiol Suppl 2005; 15 (Suppl 5): E98 - 103.